Reata Pharmaceuticals Inc. – ‘8-K’ for 4/15/21 – ‘EXCEL’

On:  Thursday, 4/15/21, at 6:50am ET   ·   For:  4/15/21   ·   Accession #:  1564590-21-18897   ·   File #:  1-37785

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     42K 
 2: EX-10.1     Material Contract                                   HTML     92K 
 3: EX-10.2     Material Contract                                   HTML     92K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     17K 
 9: R1          Document and Entity Information                     HTML     46K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- reta-8k_20210415_htm                XML     15K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 6: EX-101.LAB  XBRL Labels -- reta-20210415_lab                     XML     56K 
 7: EX-101.PRE  XBRL Presentations -- reta-20210415_pre              XML     34K 
 5: EX-101.SCH  XBRL Schema -- reta-20210415                         XSD     19K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
13: ZIP         XBRL Zipped Folder -- 0001564590-21-018897-xbrl      Zip     59K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/23  Reata Pharmaceuticals Inc.        10-K       12/31/22   78:13M                                    Donnelley … Solutions/FA
 2/28/22  Reata Pharmaceuticals Inc.        10-K       12/31/21   93:19M                                    ActiveDisclosure/FA
11/08/21  Reata Pharmaceuticals Inc.        S-3ASR     11/08/21    3:341K                                   Donnelley … Solutions/FA
 5/06/21  Reata Pharmaceuticals Inc.        10-Q        3/31/21   58:4.7M                                   ActiveDisclosure/FA